Search
    Skip to main content
    Advertisement

    Johnson and Johnson

    1. Business
    2. Pharmaceuticals
    3. Johnson and Johnson
    New Jersey appeals court: Beasley Allen should be disqualified from j&j talc cases Law.com14:44
    As AI enters the operating room, reports arise of botched surgeries and misidentified body parts Times LIVE11:20
    AI is ‘misidentifying body parts and creating more risks in surgeries’ The Independent10:21
    What are Wall Street analysts' target price for Johnson & Johnson stock? Barchart08:32
    This top Dividend stock could achieve a major milestone this year. Is it a buy? The Motley Fool23:03
    Is it time to reassess Johnson & Johnson (JNJ) after strong share price gains? Simply Wall St15:15
    Johnson & Johnson's getting back to double-digit growth. Has the stock become a bargain buy? The Motley Fool11:53

    Latest News

    Yesterday
    3 Earnings Winners Holding Strong in a Range-Bound Market Investing.com UK05:01 12-Feb-26
    In the last 7 days
    NIH Stops Johnson & Johnson's Blood Thinner Drug Arm In Stroke Trial After Safety Review Benzinga14:29 11-Feb-26
    Is Johnson & Johnson a Buy, Sell, or Hold in 2026? The Motley Fool21:57 10-Feb-26
    Jury Asked To 'Send A Message' To J&J As Talc Trial Wraps Law36020:01 10-Feb-26
    J&J Prevails as Stelara Buyers’ Antitrust Claims Are Dropped Bloomberg Law18:27 10-Feb-26
    Beasley Allen Seeks DQ Pause With 12,000 J&J Talc Suits at Risk Bloomberg Law17:35 10-Feb-26
    Drafting Guidance from Delaware Supreme Court on Earnouts, Efforts Obligations, and Fraud The Harvard Law School Forum on Corporate Governance07:35 10-Feb-26
    Johnson & Johnson to Participate in the Barclays 28th Annual Global Healthcare Conference Business Wire (Press Release)16:16 9-Feb-26
    Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now Zacks12:54 9-Feb-26
    As AI enters the operating room, reports arise of botched surgeries and misidentified body parts Times LIVE11:20 9-Feb-26
    AI is ‘misidentifying body parts and creating more risks in surgeries’ The Independent10:21 9-Feb-26
    As AI enters the operating room, reports arise of misidentified body parts and more The Telegraph, Calcutta07:34 9-Feb-26
    Johnson & Johnson Reports 90% AFib Freedom In Early Heart Device Study Benzinga07:27 9-Feb-26
    What is Considered a Good Stock Dividend? 2 Healthcare Stocks That Fit the Bill. The Motley Fool13:01 8-Feb-26
    Johnson & Johnson Dividend King offers safe 2.2% yield The Olympian, Washington19:30 7-Feb-26
    3rd Circ. Remands J&J Unit's Libel Suit Over Talc Study Law36020:08 6-Feb-26
    Johnson & Johnson Presents Early Outcomes from the Omny-Af Pilot Study at 2026 Af Symposium Business Wire (Press Release)19:01 6-Feb-26
    New Jersey Appeals Court: Beasley Allen Should Be Disqualified From J&J Talc Cases Law.com14:44 6-Feb-26
    FDA classifies J&J MedTech’s CEREPAK recall as Class I following patient death Verdict Medical Devices12:35 6-Feb-26
    Johnson & Johnson Is a Resilient Blue-Chip Stock and It Just Hit New All-Time Highs Barchart10:56 6-Feb-26
    Johnson & Johnson Wins Bid to Boot Beasley Allen from Talc Suit Bloomberg Law10:25 6-Feb-26
    Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know Zacks10:07 6-Feb-26
    In the last month
    Censia AI Adds Peter M. Fasolo to Board, Strengthening the Workforce Intelligence Layer for… PR Newswire (Press Release)15:27 5-Feb-26
    Is It Time To Reassess Johnson & Johnson (JNJ) After Strong Share Price Gains? Simply Wall St15:15 5-Feb-26
    J&J Seeks to Limit Investors’ Class Pathway at Supreme Court Bloomberg Law13:53 5-Feb-26
    Johnson & Johnson Named Inaugural Global Impact Award Winner by the Healthcare Businesswomen's… PR Newswire (Press Release)09:02 5-Feb-26
    Careers Day at Limerick school to showcase range of opportunities Limerick Leader04:12 5-Feb-26
    Johnson & Johnson Highlights New Scientific Evidence and Reinforces its… WebWire12:38 4-Feb-26
    Johnson & Johnson's Getting Back to Double-Digit Growth. Has the Stock Become a Bargain Buy? The Motley Fool11:53 4-Feb-26
    J&J Beats Proposed Class Action Over Band-Aid PFAS Law36020:42 3-Feb-26
    Lessons for Life Sciences Dealmakers: Earnout Language Controls, Efforts Agreements Have Teeth, Court Says JD Supra16:11 3-Feb-26
    Johnson & Johnson Releases Report on Surgeon Burnout as More than 40% Surveyed… WebWire09:50 3-Feb-26
    Johnson & Johnson’s Darzalex Faspro regimen receives FDA approval for multiple myeloma PMLiVE08:01 3-Feb-26
    How we tracked Covid updates TIME04:28 3-Feb-26
    Paul Weiss Discusses Delaware Supreme Court Ruling on Implied Covenant of Good Faith and Fair Dealing CLS Blue Sky00:42 3-Feb-26
    Johnson & Johnson to Participate in the TD Cowen 46th Annual Health Care Conference Business Wire (Press Release)16:38 2-Feb-26
    CHMP grants positive opinion for J&J’s Akeega use Pharmaceutical Technology05:53 2-Feb-26
    This Top Dividend Stock Could Achieve a Major Milestone This Year. Is It a Buy? The Motley Fool23:03 30-Jan-26
    J&J Wins Dismissal of Talc Class Suit for Medical Monitoring Bloomberg Law13:39 30-Jan-26
    Johnson & Johnson reveals expected timeline for Tempo Maidenhead move Twyford Advertiser12:07 30-Jan-26
    Johnson & Johnson’s pipeline strategy: What does 2026 have in store for the big pharma? Labiotech09:09 30-Jan-26
    What Are Wall Street Analysts' Target Price for Johnson & Johnson Stock? Barchart08:32 30-Jan-26
    Johnson & Johnson Says Akeega Wins Chmp Backing For Metastatic Prostate Cancer With BRCA1/2 Mutation RTT News08:18 30-Jan-26
    Former Johnson & Johnson site ignites legal showdown over redevelopment in N.J. town NJ.com - The Jersey Journal06:43 30-Jan-26
    J&J, Talc Unit Get Patients' Bankruptcy Fraud Claims Tossed Law36023:03 29-Jan-26
    US judge tosses lawsuit accusing J&J of fraud over talc bankruptcy strategy Yahoo! US18:44 29-Jan-26
    1 Dividend King to Buy and Hold Through Any Market Barchart16:15 29-Jan-26
    The Zacks Analyst Blog Johnson & Johnson, Netflix, Arista Networks, Omega and AXIL Zacks04:57 29-Jan-26
    J&J’s Rybrevant-Lazcluze sales double in 2025 as UK NICE flips to a positive call Korea Biomedical Review23:51 28-Jan-26
    Top Stock Reports for Johnson & Johnson, Netflix & Arista Networks Zacks18:14 28-Jan-26
    Dividend Growers: 2 Stocks That Could Be Worth $1 Trillion in 7 Years The Motley Fool14:05 28-Jan-26
    Texas Instruments, Circle, Johnson & Johnson: Top Analyst Calls Yahoo! UK & Ireland10:29 28-Jan-26
    ADVISORY: Maine Advises Pause for Johnson and Johnson COVID-19 Vaccine Maine Governor (Press Release)10:02 28-Jan-26
    Johnson & Johnson Stock Forecast: Trending Bullish Among Analysts TipRanks09:03 28-Jan-26
    Dow Analyst Moves: JNJ Nasdaq12:11 27-Jan-26
    Johnson & Johnson sued by BMS subsidiary in UPC’s first CAR-T patent dispute IAM09:25 27-Jan-26
    Johnson & Johnson Marks $100 Million of MedTech Products Donated Since 2020 to Help People Live, See and Smile Johnson & Johnson (Press Release)08:00 27-Jan-26
    What is asthma? Johnson & Johnson (Press Release)07:04 27-Jan-26
    J&J Ruling Offers Path for Deferred-Payment M&A Deals Gone Bad Bloomberg Law05:03 27-Jan-26
    The 3 Dividend Stocks I Think Every Investor Should Own Right Now 24/7 Wall St.14:18 26-Jan-26
    Here's Why Johnson & Johnson (JNJ) is a Strong Momentum Stock Zacks10:50 26-Jan-26
    Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It Zacks10:10 26-Jan-26
    Johnson & Johnson venture arm backs new Cambridge biotech Bizjournals16:39 25-Jan-26
    Pitiless Cut: Blood money for a broken hip The Economic Times22:29 24-Jan-26
    Johnson & Johnson confirms plan to relocate Wycombe employees to Maidenhead Bucks Free Press15:00 24-Jan-26
    Paraquat, J&J Talc Litigation Headline Philly's 2026 Mass Torts Law36021:15 23-Jan-26
    Delaware Supreme Court’s Earnout Decision Reinforces Primacy of Contract and Illustrates the Limits of the Implied… JD Supra15:16 23-Jan-26
    ETFs to Buy Post JNJ's Q4 Earnings Surprise & Bullish Cash Flow View Zacks14:04 23-Jan-26
    Are drugmakers talking to us or Trump when they promise new NC factories? News & Observer, North Carolina10:15 23-Jan-26
    Pharma: J&J's broadening product pipeline can bring 'new era' Yahoo! UK & Ireland07:40 23-Jan-26
    A 75-Year-Old Holds NVIDIA and 4 Dividend Stocks—Should He Simplify Now? 24/7 Wall St.07:36 23-Jan-26
    Is This Dividend King a Screaming Buy? The Motley Fool05:13 23-Jan-26
    Johnson & Johnson to relocate Wycombe base staff BBC01:53 23-Jan-26
    Noteworthy Thursday Option Activity: JNJ, RUN, PFE Nasdaq15:47 22-Jan-26
    Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio Zacks12:45 22-Jan-26
    Johnson & Johnson Analyst Raises Price Target On Several Tailwinds In 2026 Benzinga11:04 22-Jan-26
    Playing It Safe at 70 With $2.5 Million Is Likely To Backfire 24/7 Wall St.10:14 22-Jan-26
    J&J Foresees Unprecedented $100B Year In Sales MediaPost09:52 22-Jan-26
    Johnson & Johnson Stock Trending Among Wall Street Analysts TipRanks09:08 22-Jan-26
    J&J says 2026 sales could top $100 billion pharmaphorum08:47 22-Jan-26
    Johnson & Johnson reports 9.1% increase in sales for Q4 2025 Pharmaceutical Business Review05:47 22-Jan-26
    This 2.4%-Yielding Dividend King Remains As Healthy As Ever The Motley Fool02:16 22-Jan-26
    Johnson & Johnson Crushes Patent, Pricing Probs Power Corridor00:03 22-Jan-26
    Judge's 639-Page Report Greenlights Talc Experts: ‘No Seismic Shifts in the Scientific Landscape' Law.com22:17 21-Jan-26
    Is This Dividend King Stock a Buy After a Major Development? The Motley Fool22:12 21-Jan-26
    Experts Can Testify On Cancer Link In J&J Talc Suits Law36019:54 21-Jan-26
    Johnson & Johnson Says Product Launches, Regulatory Approvals Drive Growth PYMNTS.com18:47 21-Jan-26
    Johnson & Johnson (JNJ) Reports Q4 Earnings: What Key Metrics Have to Say Zacks17:33 21-Jan-26
    Johnson & Johnson (JNJ) Tops Q4 Earnings and Revenue Estimates Zacks17:23 21-Jan-26
    Small cap wrap: American Resources, C3 Metals, TNR Gold, AtaiBeckley... Proactive Investors (US)15:36 21-Jan-26
    Experts Can Testify About Suspected J&J Talc Cancer Link, Special Master Recommends Insurance Claims Journal14:37 21-Jan-26
    Market movers: Kraft Heinz, Lisata Therapeutics, Halliburton, Johnson & Johnson... Proactive Investors (US)14:35 21-Jan-26
    Will jobs be impacted as Johnson & Johnson leaves Wycombe? Bucks Free Press13:46 21-Jan-26
    Johnson & Johnson's closure marks 'end of an era' for Wycombe Bucks Free Press13:46 21-Jan-26
    AtaiBeckley seen as key beneficiary of Spravato’s strong growth: Jefferies Proactive Investors (US)13:03 21-Jan-26
    Nasdaq Edges Lower; Johnson & Johnson Earnings Top Estimates Benzinga12:18 21-Jan-26
    Johnson & Johnson Talc Plaintiffs Clear Key Expert Testimony Hurdle Benzinga12:02 21-Jan-26
    J&J's 2026 guidance driven by 'exciting' new product story Yahoo! UK & Ireland11:39 21-Jan-26
    J&J eyes $100B in sales amid gains for cancer, immune drugs BioPharma Dive11:19 21-Jan-26
    Johnson & Johnson Beats Revenue While EPS Miss Keeps the Stock in Check Investing.com UK11:09 21-Jan-26
    Johnson & Johnson forecasts profit above estimates Kuwait Times10:39 21-Jan-26
    Johnson & Johnson reports Q4 earnings beat, issues 2026 guidance above forecasts Proactive Investors (US)09:19 21-Jan-26
    Experts Can Testify About Suspected J&J Talc Products’ Cancer Link Insurance Journal08:35 21-Jan-26
    Genmab Announces 23% Annual Increase In 2025 Darzalex Sales RTT News08:34 21-Jan-26
    Johnson & Johnson expects further growth in 2026 as Q4 earnings jump ShareCast08:27 21-Jan-26
    Johnson & Johnson Expects 2026 Sales To Hit Almost $100 Billion Benzinga08:04 21-Jan-26
    Johnson & Johnson bullish on 2026 outlook after deal with US administration Irish Examiner07:29 21-Jan-26
    Johnson & Johnson Guides FY26 Sales Above Estimates - Update RTT News06:48 21-Jan-26
    Johnson & Johnson forecasts 2026 profit above Wall Street estimates Yahoo! US06:29 21-Jan-26
    Johnson & Johnson reports Q4 and Full-Year 2025 results Business Wire (Press Release)06:20 21-Jan-26
    Stock Market Today: Dow Jones, S&P 500 Futures Recover As Focus Turns To Trump's Davos Address—Johnson & Johnson,… Benzinga05:17 21-Jan-26
    Experts can testify about suspected Johnson & Johnson talc products' cancer link, special master recommends The Telegraph, Calcutta04:36 21-Jan-26
    Dow Jones futures gain after Wall Street suffers October-level slump FXstreet04:05 21-Jan-26
    Johnson & Johnson Foundation, Skoll Foundation and Comic Relief UK Commit Nearly US$15 Million to Strengthen Community… The Global Fund (Press Release)03:38 21-Jan-26
    JNJ Earnings Preview: Solid Q4 Expected With Revenue Growth Above 5% in Sight Investing.com UK03:10 21-Jan-26
    view more headlines
    12 Feb 05:01

    About our Johnson & Johnson news

    Latest news on Johnson & Johnson, the American multinational pharmaceutical, known for developing healthcare, pharmaceuticals, and consumer products. Stay updated on stories about their pioneering medical advancements, including vaccines, treatments, and medical devices. Explore insights into the company’s financial performance, share prices, leadership changes, and global strategies.

    Pharmaceuticals Top Stories

    FDA refuses to review Moderna's mRNA flu vaccine Bursa.ro17:08
    First-of-its-kind device for pancreatic cancer wins FDA approval Medpage Today13:13
    Encora Therapeutics gains FDA clearance for essential tremor device Verdict Medical Devices12:49
    A French pharma group rediscovering its joie de vivre Investors Chronicle12:17
    Alnylam turns profitable even as Amvuttra Attr revenue disappoints in Q4 FiercePharma11:11

    Business Top Stories

    5 Best artificial intelligence stocks to buy in February The Motley Fool04:34Apple AI IT
    Amazon, Microsoft, and Alphabet stocks plummet on AI investments. These 3 stocks are set to win. The Motley Fool17:23Apple AI IT
    Best Growth Stock to buy right now: Amazon vs. MercadoLibre The Motley Fool04:03Amazon
    Amazon just achieved this major milestone that only 1 other company has done since 2001 The Motley Fool05:35Amazon
    Morgan Stanley says to buy these 2 crypto stocks that are pivoting to AI and primed for 150%… Business Insider17:26Morgan Stanley AI IT
    These 5 software stocks could double in price this year, says Morgan Stanley Investopedia07:37Morgan Stanley AI IT
    1 Reason to buy Alphabet stock hand over fist The Motley Fool18:24Alphabet Google Top Tech Brands
    What does Alphabet’s $31.5 Billion bond sale really mean for GOOGL stock investors? Barchart12:15Alphabet Google Top Tech Brands
    Trump’s EPA rollbacks will reverberate for ‘Decades’ Insurance Journal01:32EPA Insurance Business (US)
    In one swoop, Trump kills US greenhouse gas regulations The Verge14:36EPA Insurance Business (US)
    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.